chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Cough, Acute hypoxemic respiratory failure  ED to Hosp-Admission  Discharged  8/23/2021 - 8/28/2021 (5 days)  Hospital  covid, hypoxia, htn Presenting Problem/History of Present Illness/Reason for Admission COVID-19 virus infection     Hospital Course   60-year-old female presented with acute respiratory insufficiency secondary to COVID-19 pneumonia with bilateral infiltrates on CT scan and negative for PE   She was placed on oxygen had convalescent plasma and a 5-day course of remdesivir and she started on dexamethasone 6 mg daily   Her oxygen was weaned to room air but needs 6 L with exertion and sleep and she is on room air with being awake at rest   She has essential hypertension she presented with severe hypokalemia the potassium was 2.6 her blood pressures were on the low side we held her blood pressure medication she had AKI as well her losartan was held as well   The AKI resolved the hypokalemia resolved with replacement and we restarted her on her blood pressure medications amlodipine and losartan but hold the hydrochlorothiazide which she might restart at home depending on what her blood pressures are.  The blood pressure at the time of discharge is 130/80 with a heart rate of 70
No adverse effects; one separate dose of an improperly stored vaccine, PEDVAXHIB was administered to one separate patient.; Information has been received from a medical assistant, referring to a patient of unknown age and gender. Information of concomitant therapy, pertinent medical history and drug reactions/allergies was not reported.    On 11-JUN-2019, the patient was vaccinated with improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) 0.5 milliliter (one dose, lot# R021077, expiration date: 11-JUN-2021, frequency was unknown) intramuscularly for prophylaxis (incorrect product storage). No adverse effect was reported.  The vaccines were exposed to temperature of 34.2 Fahrenheit (F) for 4 hour 54 minutes. The temperature excursion was detected by a data logger. No previous excursions were reported.  This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-1906USA011674:
Adult Pfizer vial was used to give vaccine and was diluted as a child vial.  Discovered after child/parent had left the building   Spoke with child's mother at 1155 on 12/10/2022.  Informed mom of adverse event in wrong vial used.  Explained no known negative effects with this type of error..  Mom states that patient has done just fine with only complaint of some soreness in arm.  Encouraged mom to phone us with any concerns if they would arise.  Questions encouraged and answered .  Mom verbalizes understanding.
Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 11-Mar-2022; Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 11-Mar-2022; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 11-Mar-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 11-Mar-2022) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2022 at 1:03 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 11-Mar-2022 at 1:03 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 11-Mar-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 11-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 11-Mar-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 11-Mar-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021, this vaccine was administered up until its manufacturing expiry date of 4 April 2022.  No treatment information was provided by the reporter.   This case was linked to MOD-2022-542869.
Patient's step -father called to the HD and reports that he received a call from the school nurse stating that the patient was reporting "feeling weird, seeing double and having a hard time focusing".
intense virus/flu like symptoms on my back for 5-7 days can't even due self care & house care 5 months post ~ continued muscular and v=nervous system pain throughout body, but most intense on left side...shoulder, neck, back, hip, leg, ankle, foot
I have joint pain all over my body.  As of this entry I am still in pain everywhere.  I had no pain prior to the shot.
pt seen at ED for dyspnea and hypoxia; positive for COVID; transferred to another hospital for advanced care; on 4 - 8 L O2 via NC; PMH:  HTN, OSA; started on decadron, remdisivir, Lovenox, Baricitinib; eventually required Vapotherm then full BiPAP support; transitioned to comfort care due to worsening condition; pt died in the hosp
I woke up two days later with sore throat and earache and jaw hurting on the right side and sharp pain behind the ear felt like it was in my head
Diffuse maculopapular rash with some wheals - initial onset the day following vaccine, initially appeared to upper extremities with redness of hands and knees; intermittent fever (tmax 100) x3 days in a row
Patient reports feeling chills and fatigue starting the night on the same day of receiving the SHINGRIX. The next day, the patient started having redness and itchiness on her abdomen and back for the next 4-5 days.
Initial report received from a health care professional on 13 June 2007. A 35 year old (with no medical history), inflammation of the lymph nodes on the neck, armpit and groin area, 1 week after she received DECAVAC (lot number U195386A, site of administration not reported) intramuscularly, TUBERSOL (lot number C2671AA, site of administration not reported) and MMR (Merck, lot number 0182U, site not reported) subsequently on 01 June 2007. Her lymph nodes were also painful. At the time of vaccination, she did not have any illness and was not taking any medications. The physician recommended fluid therapy and anti-inflammatory. At the time of the report, the patient had not recovered. Follow-up information received on 30 July 2007 from a health care professional. The reporter provided information pertaining to vaccine and TB test administration. DECAVAC dosage 0.5cc had been administered in the patient's right arm, TUBERSOL dosage 0.1cc with an expiration date of 21 June 2009 had been administered in the patient's left forearm, and MMR dosage 0.5cc had been administered in the patient's left arm. Diagnostic tests and laboratory data were listed as "not applicable". The patient had no illness at the time of vaccination and their recovery status was listed as recovered. No additional information was provided.
Presented at PCP's office for progressive shortness of breath for the past few days.  During visit patient had a syncopal episode regained consciousness then lost pulse for which she received 4 minutes of resuscitative care with chest compressions.  She did regain a pulse after about 4 minutes of chest compressions.  During that time emergency room physician said he saw a slow narrow complex rhythm.  No reports of ventricular arrhythmias.  Troponin and d-dimer were elevated. Heparin was started in the ED. During stay she was started on warfarin and bridging with heparin.
Rash (L) arm - ? Zoster shot. None in dermatome - Tx Acyclovir.
No additional AE reported; HCP reporting a patient received her first dose of ROTATEQ at age 4 months old.; This spontaneous report was received from registered nurse and refers to a 4-months-old female patient. The patient's concomitant medications included famotidine, and the patient's historical vaccine included diphtheria vaccine toxoid hepatitis b vaccine rhbsag (yeast) (VAXELIS) and pneumococcal vaccine conj 7v (crm197) (PREVNAR). The patient's concurrent conditions and pertinent medical history was not reported.   On 08-AUG-2022, the patient received her first rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, administered orally for prophylaxis, lot number W004503 who had been verified to be a valid number and expiration date: 15-MAY-2023 (strength, dose, and frequency, were not provided) (product administered to patient of inappropriate age). It was reported that mistake was recognized and patient tolerated. Manufacturer was contacted for further instruction and they were told to complete the series. It was reported that after 7 days that the vaccine was given there was no known adverse reaction. It was reported that the patient was recovered from the event on an unknown date in August 2022.
Patient became weak clammy and sweaty after administration of shot - Eyes rolled back into head and last consciousness for several seconds; Pulse low; HB low - Paramedic responds
Approximately 8 hours after receiving the vaccine she began noticing itchy throat, eyes, ears, nasal congestion and sneezing. These symptoms lasted for about 48 hours.
No reaction following  first injection other than arm soreness. Within 12 hours of the second dose, I became febrile, fatigued, chilled, muscle and joint pain, as well as overall exhaustion. My fevers ranged from 99-102 starting the morning of 7/21. I was unable to work the rest of the week and felt horrible throughout the weekend. By Saturday, 7/25 my tonsils became inflamed and red and the fevers continued with minimal relief. By Sunday 7/26 my tonsils were covered in white patches and ulcerations with continued 99-102 fevers. Monday the symptoms progressed with consistent fevers despite tylenol and ibuprofen.  I have been so sick I cannot get out of bed. Tuesday 7/27 I had a virtual visit with my primary care office and was started on a z-pak. The first doses were taken on the same day, 7/27. Tuesday overnight the fevers continued and I began vomiting. By today, Wednesday 7/28, I have consistently had a 99-102 fever despite antibiotics and rotating Tylenol and ibuprofen. I feel absolutely horrible. I am still vomiting, having diarrhea, cannot swallow due to the tonsil swelling and ulcerations, as well the fatigue and overall chills and joint pain. I have lost 11 lbs over the last 4 days and my fever is currently 102.9 after Tylenol an hour ago.
pt vax w/ hepta B. pt exp dull, constant left side chest pain, diaphoresis, malaise, myalgia, and tachycardia.  Sx persisted for 24 hrs, during which time pt remained in bed.
1/27/21@2200- Local Symptoms: Pain-discomfort. 2/18/21- Local  Symptoms: Pain-discomfort, General Symptoms: Chills, joint pains, muscle pains. Narrative:   Other Relevant History:
Oral TYPHOID taken 8/22 - On 8/23 he felt "feverish and sore". Took another dose 8/28 - developed fever, swollen glands in neck, face. In the evening developed swelling in joints especially knees and fingers. It was very painful and warm to touch. Symptoms resolved within 72 hours.
Tested positive for COVID19; Tested positive for COVID19; Sore throat; congestion; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 23 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 23Dec2021 (Lot number: FF2587) at the age of 23 years as dose 3 (booster), single, administration date 18Feb2021 (Lot number: EL3247) as dose 2, single and administration date 27Jan2021 (Lot number: EL3247) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant) with onset 16Jan2022, outcome "unknown", COVID-19 (medically significant) with onset 16Jan2022, outcome "recovered" and all described as "Tested positive for COVID19"; OROPHARYNGEAL PAIN (non-serious) with onset 16Jan2022, outcome "recovered", described as "Sore throat"; NASAL CONGESTION (non-serious) with onset 16Jan2022, outcome "recovered", described as "congestion". The events "tested positive for covid19", "tested positive for covid19", "sore throat" and "congestion" were evaluated at the emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test (Nasal Swab): (16Jan2022) positive. Therapeutic measures were not taken as a result of covid-19, oropharyngeal pain, nasal congestion. The patient did not take other vaccine in four weeks, she did not have a covid prior vaccination and tested for covid post vaccination.
Seen at Urgent care 8/27/17 and given Keflex 500 mg TID as well as a "steroid pill". On 8/28/17 phone advice given by RN to add Benadryl OTC and use ice pack as needed. Seen by PCP on 8/30/17: HPI 74-year-old female who presents today complaining of a reaction to the pneumonia vaccine. She had it on Friday and immediately started having erythema and pain in the arm by that evening. She started having discoloration and mottling of the arm. She notes that the swelling went away fairly quickly she has only taken 10 doses of Keflex and they gave her a 7 day course. She doesn't feel well on antibiotics so she is having some generalized discomfort and does not feel great but she doesn't have any  fever. She was having some chills initially. She did have some arm pain with this. Her redness started to resolve in 48 hours and took 72-96 hours to completely resolve. Suspect this is not cellulitis but was an acute inflammatory reaction to the pneumonia 23 vaccine.
This was reported by a physician's assistant and describes an unspecified number of unidentified patients who did not respond to immunization with Hepatitis A inactivated vaccine (Havrix) and Hepatitis B vaccine recombinant (Engerix-B).  The patient's medical history, concurrent conditions, and concurrent medications were not reported.  The patient received an unspecified number of injections of Havrix and Engerix-B.  At an unspecified time post-immunization, it was determined that the patient failed to seroconvert.  Report received via Merck and Co, Inc.
A few minutes after receiving vaccine, patient started getting clammy and was sweating all over. Then proceeded to lose vision in both eyes and eventually passed out. Regained consciousness after a few minutes and was fine.
High pitched scream only when sleeping, runny nose, cough, irregular breathing patter, low grade fever lasting for 2 weeks until treated with natural medicine.
First dose, from 1 hour after vaccine to 24 hours later experienced nausea, headache, body aches, and chills.  No fever.  Body aches were severe enough to prevent sleep all night.  Taking ibuprofen has little effect.  Lifted following afternoon.  Second dose was 10/2/2020 at 1PM.  Reaction started about 10 hours later (11 PM) and lasted about the same amount of time, but was less severe and taking ibuprofen allowed sleep.  Lifted around bedtime the following day (about 24 hours after started.
This spontaneous report as received from a medical assistant refers to unspecified number of patients of unknown age and gender. Medical history was not reported. The medical assistant informed that on unknown dates the patients were vaccinated with improperly stored doses of GARDASIL injection (route, dosage and lot numbers were not reported). No symptoms reported. The outcome of the event was unknown. The health care professional contacted during telephone follow-up could not supply the following information: patients' names, dates of birth, dates of vaccination, dose numbers and lot numbers. This is one of several reports received from the same reporter. Additional information has been requested.
About 6 months post booster shot came down with COVID-19. Evening of April 29, began having horrible sore throat. Used OTC drugs for sore throat with minimal relief. April 30th, throat pain was much worse and could hardly eat. Also began have thick white mucus and fever in the evening time. May 1st, had fever all day and the highest it got was 102. May 2nd, went to see doctor. Tested positive for COVID-19. Wednesday May 4th, symptoms began to resolve but coughing began. Thursday May 5th, fever free. May 7th-8th, all symptoms resolved. Still experienced fatigue off and on. Also began having very short spells of vertigo.
had Bells Palsy for 7 months after the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of BELL'S PALSY (had Bells Palsy for 7 months after the vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BELL'S PALSY (had Bells Palsy for 7 months after the vaccine). At the time of the report, BELL'S PALSY (had Bells Palsy for 7 months after the vaccine) outcome was unknown.            No Concomitants and Treatment medication were reported.  Company Comment; This case concerns a male patient of unknown age, with no relevant medical history, who experienced the non serious expected AESI of Bell's palsy. The event occurred at an unknown date after the mRNA-1273 vaccine, dose number not provided. The rechallenge was not applicable since dose number was not provided. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This case concerns a male patient of unknown age, with no relevant medical history, who experienced the non serious expected AESI of Bell's palsy. The event occurred at an unknown date after the mRNA-1273 vaccine, dose number not provided. The rechallenge was not applicable since dose number was not provided. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Itchiness observed 8 days after COVID vaccination (2nd booster shot) which started on my feet and legs, but quickly spread throughout my body.  I took Loratadine and used calamine lotion on my skin which now showed red marks, but that didn't seem to work.  I then went to an Urgent Care center where I was prescribed Prednisone 6-day multipack.  This helped a bit, but the itchiness and red marks were still there.  After seeing my primary doctor in early July 2022, she sent me to an allergist.  He diagnosed the red marks as hives; no allergy test was ever performed.  On my own, I decided to go to a dermatologist.  She also diagnosed it as hives but questioned me about my COVID vacs.  After I discussed the dates with her, she informed me that other patients complained of adverse skin reactions
pt recvd vax; fussiness began w/ 1st dtp,hib & opv;was adm to hosp 2 days later w/ hypernatremic dehydration; 10% weight loss; high fever 105.1; mild pneumonia & ROM;
Starting 06/13/2022, I had a sore throat and body aches/joint aches (knees and ankles mainly) and fatigue. I went to patient first and was tested but was negative. So, the PA who saw my husband said I likely was coming down with COVID due to the red sore throat. By 06/15/2022, I tested myself with an at home test due to developing a cough and it was positive. I went to the urgent care again, they did a rapid test which was positive. My cough wasn't constant but still bothersome. I took acetaminophen/ADVIL for the aches/pains. I was informed by this PA that I should not do the antivirals. So, by that Thursday, 06/16/2022, I called my doctor to see if they could give me the antivirals but again they didn't recommend it due to the possible rebound infection. My symptoms lasted for 7 days. I had fatigue that lasted for about a week after recovering.
Consumer reports that following vax in 1990, exp a swollen arm (size of 1/2 grapefruit), bronchospasm & itching approx 45 mins p/vax administered; Taken to ER; tx Atarax & cortisone;
Developed cervical adenopathy about 1 week after the vaccine.  Subsequent evaluation has demonstrated tumor in the tongue.  Undergoing evaluation now for probable carcinoma of the head and neck with biopsy and PET scan scheduled.
Vaccine administered out of age range. Quadracel is approved for 4-6 yrs old, but was given to a 7 yr old. No treatment or additional vaccines necessary. Mother of child notified. Pt did not have any adverse side effects.
This case was reported by a retired nurse via call center representative and described the occurrence of discomfort in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX and an unknown time after starting ibuprofen, the patient experienced discomfort, pruritus, fever and prostration. The patient was treated with ibuprofen. Rechallenge with SHINGRIX was positive. On an unknown date, the outcome of the discomfort, pruritus, fever and prostration were unknown. It was unknown if the reporter considered the discomfort, pruritus, fever and prostration to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingles vaccine in right deltoid, and experienced continued discomfort and itching, extreme prostration. She reported after both doses of her SHINGRIX vaccines, she had a temperature of 103, even after taking ibuprofen. She did not know lot number, expiration date, and/or did not provide other details at the time of initial chat. This case has been linked with case US2019GSK056063, reported by the same reporter. Lab Comments: On unknown date, body temperature was measured.
had 1st rotavirus vaccine at 2 months of age and had blood in stool x 2 days: no further rotavirus vaccines.
Hospitalized for dizziness, slowed respiration, somnolence & h/a; tx w/Adrenlin & sterioids in low doses, then DPH;
Patient states that after 1 month his arm is still painful. He can not sleep on that arm. He also states pain when raising arm and a numbness or weakness in his left hand.
BODY ACHES; TREMOR; CHILLS; This spontaneous report received from a patient concerned a 52 year old female. The patient's weight was 143 pounds, and height was 61 inches. The patient's concurrent conditions included: alcohol user, and non-smoker, and other pre-existing medical conditions included: The patient had no known allergy and no history of illicit drug use. The patient was previously treated with methylphenidate. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042172117, and expiry: UNKNOWN) dose was not reported, administered on 05-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On 06-AUG-2021, the patient experienced body aches. On 06-AUG-2021, the patient experienced tremor. On 06-AUG-2021, the patient experienced chills. Treatment medications (dates unspecified) included: acetylsalicylic acid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches on 06-AUG-2021, and had not recovered from chills, and tremor. This report was non-serious.
Pt stated to pharmacist on 4/8/21 that she got a case of shingles around one side of  her mouth approximately 2 days after receiving the vaccination.  There were no medications prescribed for treatment.
Status epilepticus in adolescent with well-controlled epilepsy, last seizure 9/2020. Seizures began 31 hours after second dose of Pfizer Covid vaccine. Headache, chills, myalgias, fatigue began 15 hours after second dose. Tylenol had been given to manage headaches about three times before seizures began. Fever to 101 was noted by EMS and in ER, no fevers had been noted before then.